The Bureau of Labor Statistics (BLS) released its June 2026 Import and Export Price Indexes on July 17, and the headline read tame: import prices rose 0.3% for the month. The 12-month figure was not tame. Import prices were up 7.1% from June 2025, the largest annual increase since August 2022 (BLS). Inside that number is a line that matters more to loss reserves than the top print: capital-goods import prices rose 0.4% in June, and BLS named scientific and medical machinery among the drivers, alongside computers, semiconductors, and industrial machinery. Imported medical equipment costs keep rising even as broader goods inflation cools.
Who it affects
The exposure runs across three self-insured groups that rarely think of themselves as sharing a cost driver. Self-insured hospitals and health systems carry imported scientific, diagnostic, and surgical equipment in both their capital budgets and their professional-liability medical-cost base. Self-funded health plans pay for imported devices, implants, and durable medical equipment inside large claims. Workers’ compensation payers, including public-entity pools and single-parent captives, fund durable medical equipment (DME) such as imaging, prosthetics, and mobility devices on serious injury claims. When the import price of that equipment climbs 7.1% over a year, the cost shows up in claim severity regardless of what the headline consumer index does.
The reserve mechanism: severity, not frequency
This is a severity signal, and specifically a medical-severity signal. Frequency is untouched; the same injuries and admissions cost more because a component of the medical bill, imported equipment and supplies, is inflating faster than the blended trend suggests. The trap is decomposition. Most medical severity trend selections are a single blended number that folds together wage-driven service cost, utilization, and equipment and supply cost. When a buyer sees a calm medical Consumer Price Index (CPI) print, the equipment line is the piece hiding inside the average. A 7.1% imported-goods trend against a low-single-digit blended assumption is the gap that produces adverse development on long-tail medical claims, where equipment and device costs land years after the accident date.
The automotive contrast sharpens the point. Automotive vehicles, parts, and engines import prices edged down 0.1% in June. That split matters for mixed portfolios: it argues for firmer injury and medical-severity assumptions while physical-damage and auto-parts severity stays softer. Do not let a flat auto-parts line pull down a medical trend selection built on different inputs.
Where this shows up in your reserves
On a workers’ comp triangle, watch the medical paid and incurred development at 24-plus months, where DME and durable device costs concentrate; a widening paid-to-incurred gap there is the tell. On a self-funded health reconciliation, it surfaces in the large-claim (over $500,000) layer where implants and devices sit. For a hospital captive, it lands in the medical-cost component of professional-liability severity. See what’s driving your IBNR higher, hospital professional liability IBNR, and IBNR for self-funded health plans for where the line sits in each structure. This import read reinforces the NCCI tariff signal on WC medical equipment and the split-severity theme in the June PPI and headline CPI reads.
Decision-maker checklist
- Ask your actuary whether the medical severity trend selection breaks out an equipment and supply component or is a single blended number.
- Quantify your DME and device spend as a share of medical loss, and flag its imported-goods exposure.
- If your headline medical CPI looks flat, name the independent signals used to test whether severity is genuinely cooling.
- Watch the next PPI and CPI medical-equipment components to confirm or contradict this import-price read before locking a trend assumption.